These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37142421)

  • 1. Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality.
    de Brabander J; Boers LS; Kullberg RFJ; Zhang S; Nossent EJ; Heunks LMA; Vlaar APJ; Bonta PI; Schultz MJ; van der Poll T; Duitman J; Bos LDJ; ; ; ;
    Thorax; 2023 Sep; 78(9):912-921. PubMed ID: 37142421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alveolar fibroproliferative response in moderate to severe COVID-19-related acute respiratory distress syndrome and 1-yr follow-up.
    Zhang S; Boers LS; de Brabander J; van den Heuvel LB; Blok SG; Kullberg RFJ; Smids-Dierdorp BS; Dekker T; Aberson HL; Meijboom LJ; Vlaar APJ; Heunks L; Nossent EJ; van der Poll T; Bos LDJ; Duitman J;
    Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L7-L18. PubMed ID: 37933449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDS.
    Bendib I; Beldi-Ferchiou A; Schlemmer F; Surenaud M; Maitre B; Plonquet A; Carteaux G; Razazi K; Godot V; Hüe S; Mekontso Dessap A; de Prost N
    Crit Care; 2021 Jan; 25(1):23. PubMed ID: 33422148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS.
    Blot M; Jacquier M; Aho Glele LS; Beltramo G; Nguyen M; Bonniaud P; Prin S; Andreu P; Bouhemad B; Bour JB; Binquet C; Piroth L; Pais de Barros JP; Masson D; Quenot JP; Charles PE;
    Crit Care; 2020 Nov; 24(1):632. PubMed ID: 33138839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.
    Nossent EJ; Schuurman AR; Reijnders TDY; Saris A; Jongerius I; Blok SG; de Vries H; Duitman J; Vonk Noordegraaf A; Meijboom LJ; Lutter R; Heunks L; Bogaard HJ; van der Poll T
    Front Immunol; 2021; 12():664209. PubMed ID: 34054832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) Is Elevated in Bronchoalveolar Lavage Fluid of Patients with Acute Respiratory Distress Syndrome.
    Attia EF; Jolley SE; Crothers K; Schnapp LM; Liles WC
    PLoS One; 2016; 11(2):e0149687. PubMed ID: 26919714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
    Ouwendijk WJD; Raadsen MP; van Kampen JJA; Verdijk RM; von der Thusen JH; Guo L; Hoek RAS; van den Akker JPC; Endeman H; Langerak T; Molenkamp R; Gommers D; Koopmans MPG; van Gorp ECM; Verjans GMGM; Haagmans BL
    J Infect Dis; 2021 May; 223(9):1512-1521. PubMed ID: 33507309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble programmed cell death receptor-1 (sPD-1): a potential biomarker with anti-inflammatory properties in human and experimental acute respiratory distress syndrome (ARDS).
    Monaghan SF; Chung CS; Chen Y; Lomas-Neira J; Fairbrother WG; Heffernan DS; Cioffi WG; Ayala A
    J Transl Med; 2016 Nov; 14(1):312. PubMed ID: 27835962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival.
    Lesur O; Kokis A; Hermans C; Fülöp T; Bernard A; Lane D
    Crit Care Med; 2000 Dec; 28(12):3814-22. PubMed ID: 11153619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T regulatory cells activation and distribution are modified in critically ill patients with acute respiratory distress syndrome: A prospective single-centre observational study.
    Halter S; Aimade L; Barbié M; Brisson H; Rouby JJ; Langeron O; Klatzmann D; Rosenzwajg M; Monsel A
    Anaesth Crit Care Pain Med; 2020 Feb; 39(1):35-44. PubMed ID: 31374365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome.
    Venet F; Cour M; Rimmelé T; Viel S; Yonis H; Coudereau R; Amaz C; Abraham P; Monard C; Casalegno JS; Brengel-Pesce K; Lukaszewicz AC; Argaud L; Monneret G;
    Crit Care; 2021 Apr; 25(1):140. PubMed ID: 33845874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS.
    Hamid U; Krasnodembskaya A; Fitzgerald M; Shyamsundar M; Kissenpfennig A; Scott C; Lefrancais E; Looney MR; Verghis R; Scott J; Simpson AJ; McNamee J; McAuley DF; O'Kane CM
    Thorax; 2017 Nov; 72(11):971-980. PubMed ID: 28082531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome.
    Nathani N; Perkins GD; Tunnicliffe W; Murphy N; Manji M; Thickett DR
    Crit Care; 2008; 12(1):R12. PubMed ID: 18269741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia.
    Mikacenic C; Moore R; Dmyterko V; West TE; Altemeier WA; Liles WC; Lood C
    Crit Care; 2018 Dec; 22(1):358. PubMed ID: 30587204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome.
    Steinberg KP; Milberg JA; Martin TR; Maunder RJ; Cockrill BA; Hudson LD
    Am J Respir Crit Care Med; 1994 Jul; 150(1):113-22. PubMed ID: 8025736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammasome-regulated cytokines are critical mediators of acute lung injury.
    Dolinay T; Kim YS; Howrylak J; Hunninghake GM; An CH; Fredenburgh L; Massaro AF; Rogers A; Gazourian L; Nakahira K; Haspel JA; Landazury R; Eppanapally S; Christie JD; Meyer NJ; Ware LB; Christiani DC; Ryter SW; Baron RM; Choi AM
    Am J Respir Crit Care Med; 2012 Jun; 185(11):1225-34. PubMed ID: 22461369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome.
    Kiehl MG; Ostermann H; Thomas M; Müller C; Cassens U; Kienast J
    Crit Care Med; 1998 Jul; 26(7):1194-9. PubMed ID: 9671368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.
    Zaid Y; Doré É; Dubuc I; Archambault AS; Flamand O; Laviolette M; Flamand N; Boilard É; Flamand L
    J Allergy Clin Immunol; 2021 Aug; 148(2):368-380.e3. PubMed ID: 34111453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for chemokine synergy during neutrophil migration in ARDS.
    Williams AE; José RJ; Mercer PF; Brealey D; Parekh D; Thickett DR; O'Kane C; McAuley DF; Chambers RC
    Thorax; 2017 Jan; 72(1):66-73. PubMed ID: 27496101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.